Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia

NCT01700842 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01700842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
December 31, 2012
Enrollment
3,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial skin diseases